Stories you may have missed from the world of business.
PHARMACEUTICAL
Patients on Eli Lilly & Co.’s experimental diabetes pill lost more weight and had better blood sugar control than those on an older, approved rival from Novo Nordisk A/S in the first head-to-head trial of the two medicines. The highest… [5694 chars]
Source: The Boston Globe | Published: 2025-09-17T21:51:09Z
Credit: The Boston Globe
